Malignant melanotic nerve sheath tumor (MMNST), formerly called melanotic schwannoma, is a rare tumor of neural crest derivation which most frequently arises from the region of spinal or autonomic nerves near the midline. Recent studies have reported malignant behavior of MMNST, and there still has no standard management guidelines. Intra-abdominal MMNST, which has never been reviewed as an entity, is even rarer. In this study, we present a rare case of a cystic MMNST arising from the para-aortic region and mimicking an intra-abdominal gastrointestinal stromal tumor (GIST), and review the literature regarding MMNSTs located in the abdominal cavity.
Case presentation
A 59-year-old female was incidentally found a tumor located in the left para-aortic area by non-contrast computed tomography. A Magnetic Resonance Imaging showed a cystic mass originated from the inferior mesenteric artery (IMA) territory. A GIST was initially diagnosed. The tumor was resected en bloc by laparoscopic surgery and was found between mesocolon and Gerota’s fascia with blood supply of IMA. Grossly, dark brown materials were noted at the inner surface of the cystic wall. Microscopically, the tumor cells were melanin-containing, and no psammomatous bodies were present. Immunohistochemically, the tumor showed positivity for MART1, HMB45, collagen IV, and SOX10, and negativity for AE1/AE3. MMNST was favored over malignant melanoma, since the tumor was located near ganglia and had cells with less atypical cytology and a low mitotic rate, and subsequent adjuvant radiotherapy was performed. The patient was alive with no evidence of recurrent or metastatic disease 11 months after radiotherapy.
Conclusions
Our review of abdominal MMNST cases showed a female predominance, with an average age of 54.8 years, and a trend toward being a larger tumor showing cystic or necrotic changes. Local recurrence and metastasis rate were reviewed, and both showed a low rate. Diagnosis of MMNST should combine all the available findings, and complete excision of the tumor should be performed, followed by long-term patient monitoring.
Hinweise
Kuan-Yu Lin and Lujen Chen contributed equally as co-first authors
Chih-Jung Chen and Kun-Yuan Chiu contributed equally as co-corresponding authors
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
MMNST
Malignant melanotic nerve sheath tumor
GIST
Gastrointestinal stromal tumor
CT
Computed tomography
MRI
Magnetic resonance imaging
IMA
Inferior mesenteric artery
M
Male
F
Female
Rt
Right
Lt
Left
Abd
Abdominal
N/A
Not available
GTR
Gross total resection
mets
Metastasis
R/T
Radiotherapy
C/T
Chemotherapy
mons
Months
yrs
Years
Background
Malignant melanotic nerve sheath tumor (MMNST), also called melanotic schwannoma, is a rare tumor of neural crest derivation composed of variably melanin-producing Schwann cells [1, 2]. MMNST, first recorded by Millar in 1932 [3], most frequently arises from the region of spinal or autonomic nerves near the midline [1]. MMNST has been reported to be associated with Carney’s complex (skin pigmentary abnormalities, myxomas, endocrine tumors, or endocrine overactivity) [2, 4, 5]. Most melanotic schwannomas are clinically benign tumors [4]. However, recent studies have reported malignant behavior of tumors that show local recurrence and metastasis [2, 6].
MMNST still has no standard treatment guidelines, and complete excision of the tumor is the most common approach. In the present study, we present a rare case of a cystic MMNST arising from the para-aortic region and mimicking an intra-abdominal gastrointestinal stromal tumor (GIST). We also discuss the radiologic and histologic features, and the literature regarding MMNSTs located in the abdominal cavity is reviewed.
Anzeige
Case presentation
A 59-year-old female was referred for a tumor located in the left para-aortic area, close to the pancreatic tail and left renal hilum, found incidentally by non-contrast computed tomography (CT) during a urolithiasis survey. This patient had a past history of hypertension, but it was under control. She was asymptomatic, without any abnormal physical examination findings.
Non-contrast CT disclosed a heterogeneous ovoid mass about 52 mm × 41 mm in size. Magnetic resonance imaging (MRI) further revealed a 4.7 cm cystic mass at the para-aortic region abutting to the 3rd and 4th portion of the duodenum (Figs. 1A, 2A). The solid part of the tumor showed hyperintensity on T1WI images and hypointensity on T2WI images (Figs. 1B, 2B). A slightly progressive enhancement was seen in the diffusely restricted portion of the solid part. The apparent diffusion coefficient value was about 1.06 × 10−3 mm2/s. The cystic part showed hypointensity on T1WI images (Fig. 1A) and hyperintensity on T2WI images (Figs. 1B, 2B), with or without fat suppression (Fig. 1C), and showed identical enhancement in contrast-enhanced T1WI (Fig. 1D). The blood supply to the cystic mass originated from the inferior mesenteric artery (IMA) territory. A gastrointestinal stromal tumor (GIST) was initially diagnosed following differential diagnosis that included paraganglioma.
×
×
Her 24-h urine vanillyl mandelic acid and catecholamine values were within the normal range. A paraganglioma was less suspected because her hypertension was less responsive to alpha-blockers.
Laparoscopic surgery was carried out with the patient in a supine position under general anesthesia in April 2021. The tumor was located between the mesocolon and Gerota’s fascia, with a feeding vessel extending from the IMA. The feeding vessel was ligated without compromising the main trunk of the IMA. The tumor was resected en bloc, and a drainage tube was placed. We discharged the patient on postoperative day 4.
Anzeige
Grossly, the specimen was a cystic tissue, 5.8 × 4 × 3.1 cm, with a smooth and partially dark-pigmented outer surface. Dark brown materials were noted at the inner surface of the cystic wall (Fig. 3A–D). Microscopy sections showed an encapsulated tumor with peripheral lymphoid cuffing and intratumoral lymphocytic infiltration (Fig. 4A). The tumor cells were melanin-containing spindled to epithelioid cells featuring pleomorphic and hyperchromatic nuclei and frequent nuclear pseudoinclusions (Fig. 4B). No psammomatous bodies were present. Mitotic activity was as high as 2 per 10 high powered fields (HPFs; 1 HPF × 400 = 0.1734 mm2). The pigment was positive for melanin staining and negative for iron staining. Immunohistochemically, the tumor showed positivity for MART1, HMB45, collagen IV, and SOX10, and negativity for AE1/AE3 (Fig. 4C–F). A neurocristic lineage and melanocytic differentiation were noted.
×
×
Malignant melanoma should be first excluded because of its poor prognosis. MMNST was favored over malignant melanoma in this case, since the tumor was located near ganglia and had cells with less atypical cytology and a low mitotic rate. The patient also did not present with a history of melanoma. The patient was given a final diagnosis of MMNST. Subsequent adjuvant radiotherapy was completed in July 2021. The patient was alive with no evidence of recurrent or metastatic disease 11 months after radiotherapy.
Discussion and conclusions
Intra-abdominal MMNST is a rare entity. We reviewed the cases of MMNST in the abdominal cavity without nerve root invasion available in the PubMed database. The features are summarized in Table 1.
Table 1
Clinicopathological features of reported intra-abdominal malignant melanotic nerve sheath tumor.
M male; F female; Rt right; Lt left; Abd abdominal; N/A not available; GTR gross total resection; mets metastasis; R/T radiotherapy; C/T chemotherapy; mons months; yrs years
Sex was available in 16 cases; 5 of the 16 were male (31.25%) and 11 were female (68.75%). Torres-Mora et al. reported 18 male and 22 female patients in 40 cases of all locations, whereas other previous studies reported no sex predilection [2, 22, 23]. The tumor in the 16 cases had an average maximum diameter of 8.55 cm, with a median of 5.7 cm, compared to a previous study reporting a median tumor size of 3.2 cm [2].
We also assessed the cystic or necrotic changes that occurred in the abdominal MMNSTs. Overall, 14 cases provided structural descriptions, and cystic or necrotic changes were mostly observed in larger sized tumors (≥ 5 cm, 7/9, 77.7%) but less frequently noted in the smaller sized tumors (< 5 cm, 1/5, 20%). All patients underwent surgical removal of the tumor, and no cases had incomplete surgical resection. Follow-up was available in 12 cases, ranging from 7 months to 60 months. The recurrence or metastatic rate were both reported for 1/12 (8%) of these patients and revealed a relatively lower rate than in recent studies [2, 24, 25]. The only patient with metastasis died despite chemotherapy and radiotherapy [8]. Another patient with local recurrence received chemotherapy, but no further follow-up information was provided [19].
MMNST, as updated and defined by the current fifth edition of the WHO classification of tumors of soft tissue and bone [1], was formerly called melanotic schwannoma or melanocytic schwannoma [1]. It is a rare tumor of neural crest derivation and is composed of variably melanin-producing Schwann cells. Fewer than 400 cases have been reported. An MMNST can be located anywhere in the peripheral nerve system and most frequently arises from the region of spinal or autonomic nerves near the midline [1, 26]. The clinical features are related to the anatomic sites and growth. Mostly associated with a mass compression effect, the clinical features could present as pain or paresthesia, or the patients are asymptomatic [1, 26].
The etiology of MMNST is still unknown. Theories have included melanomatous transformation of neoplastic Schwann cells, phagocytosis of melanin by Schwann cells, and the presence of two different neoplastic populations of proliferating melanocytes and Schwann cells [22]. An association is recognized between MMNST and Carney’s complex, an autosomal dominant inherited multiple endocrine neoplastic syndrome mostly caused by a PRKAR1A gene deficit [27]. However, the degree of relevance remains controversial, as the presentation ranges from less than 5% to over 50% [2, 4].
Abdominal MMNST often presents with nonspecific abdominal symptoms or is discovered as an incidental finding. GISTs are the most common mesenchymal tumors [19]; therefore, GISTs and MMNSTs should be distinguished. CT scan findings indicate that GISTs seldom show calcification, but calcification may be seen in some MMNSTs [7‐9, 28]. MRI findings typically show MMNST as having T1 hyperintensity and T2 hypointensity due to the presence of melanin contained in MMNST. By contrast, GISTs mostly present with opposite findings [9, 24, 29]. These differences in imaging findings may suggest that imaging is a preferable method for differential diagnosis between these two tumors; however, the final diagnosis depends on the histological findings.
Anzeige
Grossly, MMNST presents as a dark brown or black tumor, and it sometimes presents with hemorrhagic components, cyst formation, or necrosis [2]. The tumor is usually ovoid and surrounded by a thin, fibrous membrane that arises related to a nerve [26]. Microscopically, the morphology of MMNST includes spindle and epithelioid cells. Accumulation of melanin occurs in neoplastic cells and melanophages, with variations between different cells [2]. Psammomatous bodies may present occasionally and are more common in Carney’s complex-associated MMNST [6]. Immunohistochemical staining is often positive for S100, SOX10, HMB-45, Melan-A, p16, and vimentin in MMNST [25]. All reported cases of MMNST showed immunoreactions of laminin and collagen IV [30].
Genetically, mutation of the PRKAR1A gene is seen in most MMNSTs [31]. The presentation of melanotic features means that malignant melanoma is an important differential diagnosis from MMNST. Tumors with psammomatous bodies, adipose-like cells, benign or mild atypia, and lower mitotic activity would favor a diagnosis of MMNST. In addition, 90% of malignant melanomas present with BRAF V600E. Negativity for this test would also indicate MMNST [32, 33].
Gross total excision is widely accepted as the primary treatment for MMNSTs. The local recurrence rate and metastatic rate remain controversial, with < 15% stated in the past and 42% reported in more recent studies [2, 4]. MMNSTs can metastasize even without any malignant features [34]. Adjuvant radiotherapy or chemotherapy have been suggested when malignant features are presented or following incomplete surgical resection, but the effectiveness remains controversial. One study suggested that MMNST with > 2 mitosis/10 HPF should receive adjuvant therapy [34]. Some recent studies have shown an effect of anti-PD1 therapy and the use of Rexin-G® [35, 36]. Follow-up of patients for more than 5 years revealed that only 53% of patients were free of disease, suggesting the importance of long-term follow-up [5].
In this study, we reported an incidentally found intra-abdominal MMNST and reviewed the features of this entity in a total of 18 cases. This study had some limitations. MMNST is an extremely rare entity; therefore, the small sample size, inconsistent treatment protocols, and incomplete follow-up restricted the results of our study. Further evaluation of long-term follow-up and treatment are needed.
Anzeige
Intra-abdominal MMNST is a rare entity. We presented a case with an initial diagnosis of GIST that was subsequently identified as an MMNST located at the para-aortic area. Our review of abdominal MMNST cases showed a female predominance, with an average age of 54.8 years, and a trend toward being a larger tumor showing cystic or necrotic changes. Local recurrence and metastasis rate were reviewed, and both showed a low rate. Diagnosis of MMNST should combine all the available findings, and complete excision of the tumor should be performed, followed by long-term patient monitoring.
Acknowledgements
Not applicable.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Anzeige
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.
Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.
Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.